Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

1999-01-25

Original market date: See footnote 1

1996-08-16

Product name:

MAALOX HRF SUSPENSION

DIN:

02162318 Electronic product monograph is not available

Company:

NOVARTIS CONSUMER HEALTH CANADA INC.
500 7125 Mississauga Road
Mississauga
Ontario
Canada L5N 0C2

Class:

Human

Dosage form(s):

Suspension

Route(s) of administration:

Oral

Number of active ingredient(s):

3

Schedule(s):

OTC

 

American Hospital Formulary Service (AHFS): See footnote 3

56:04.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

A02BX13 ALGINIC ACID

Active ingredient group (AIG) number:See footnote5

0317794003

List of active ingredient(s)
Active ingredient(s) Strength
ALUMINUM HYDROXIDE-MAGNESIUM CARBONATE-CO DRIED GEL 280 MG / 10 ML
MAGNESIUM ALGINATE 500 MG / 10 ML
MAGNESIUM CARBONATE 350 MG / 10 ML
Version 4.0.2
Date modified: